Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023841799> ?p ?o ?g. }
- W3023841799 abstract "Abstract Triple-negative breast cancer (TNBC) is a highly aggressive disease and of poor prognosis. It is very important to identify novel biomarkers to predict therapeutic response and outcome of TNBC. We investigated the association between polymorphisms in PARP1 gene and clinicopathological characteristics or survival of 272 patients with stage I-III primary TNBC treated with anthracycline/taxane based adjuvant chemotherapy. We found that after adjusted by age, grade, tumor size, lymph node status and vascular invasion, rs7531668 TA genotype carriers had significantly better DFS rate than TT genotype carriers, the 5 y DFS was 79.3% and 69.2% ( P = 0.046, HR 0.526 95% CI 0.280–0.990). In lymph node negative subgroup, DFS of rs6664761 CC genotype carriers was much better than TT genotype carriers ( P = 0.016, HR 0.261 95% CI 0.088–0.778) and DFS of rs7531668 AA genotype carriers was shorter than TT genotype carriers ( P = 0.015, HR 3.361 95% CI 1.259–8.969). In subgroup of age ≤ 50, rs6664761 TC genotype predicted favorable DFS than TT genotype ( P = 0.042, HR 0.405 95% CI 0.170–0.967). Polymorphisms in PARP1 gene had no influence on treatment toxicities. After multivariate analysis, tumor size ( P = 0.037, HR = 2.829, 95% CI: 1.063–7.525) and lymph node status ( P < 0.001, HR = 9.943, 95% CI: 2.974–33.243) were demonstrated to be independent prognostic factors. Our results suggested that polymorphisms in PARP1 gene might predict the DFS of TNBC patients treated with anthracycline/taxane based adjuvant chemotherapy." @default.
- W3023841799 created "2020-05-13" @default.
- W3023841799 creator A5023468924 @default.
- W3023841799 creator A5027835055 @default.
- W3023841799 creator A5047233660 @default.
- W3023841799 creator A5051415080 @default.
- W3023841799 creator A5082438764 @default.
- W3023841799 date "2020-04-30" @default.
- W3023841799 modified "2023-10-02" @default.
- W3023841799 title "Polymorphisms in PARP1 predict disease-free survival of triple-negative breast cancer patients treated with anthracycline/taxane based adjuvant chemotherapy" @default.
- W3023841799 cites W1982602899 @default.
- W3023841799 cites W1985213644 @default.
- W3023841799 cites W1998683657 @default.
- W3023841799 cites W2005458257 @default.
- W3023841799 cites W2006225834 @default.
- W3023841799 cites W2009584660 @default.
- W3023841799 cites W2018543951 @default.
- W3023841799 cites W2036355280 @default.
- W3023841799 cites W2049028195 @default.
- W3023841799 cites W2049813947 @default.
- W3023841799 cites W2057706543 @default.
- W3023841799 cites W2074730941 @default.
- W3023841799 cites W2081594268 @default.
- W3023841799 cites W2090854519 @default.
- W3023841799 cites W2097255042 @default.
- W3023841799 cites W2101979288 @default.
- W3023841799 cites W2110143309 @default.
- W3023841799 cites W2113633750 @default.
- W3023841799 cites W2114505219 @default.
- W3023841799 cites W2134902059 @default.
- W3023841799 cites W2135601011 @default.
- W3023841799 cites W2137853125 @default.
- W3023841799 cites W2138929540 @default.
- W3023841799 cites W2139633106 @default.
- W3023841799 cites W2300777627 @default.
- W3023841799 cites W2331821641 @default.
- W3023841799 cites W2337622434 @default.
- W3023841799 cites W2485374269 @default.
- W3023841799 cites W2587898532 @default.
- W3023841799 cites W2744474796 @default.
- W3023841799 cites W2888851775 @default.
- W3023841799 cites W2900491285 @default.
- W3023841799 cites W2911188335 @default.
- W3023841799 doi "https://doi.org/10.1038/s41598-020-64473-8" @default.
- W3023841799 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7192942" @default.
- W3023841799 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32355298" @default.
- W3023841799 hasPublicationYear "2020" @default.
- W3023841799 type Work @default.
- W3023841799 sameAs 3023841799 @default.
- W3023841799 citedByCount "2" @default.
- W3023841799 countsByYear W30238417992022 @default.
- W3023841799 countsByYear W30238417992023 @default.
- W3023841799 crossrefType "journal-article" @default.
- W3023841799 hasAuthorship W3023841799A5023468924 @default.
- W3023841799 hasAuthorship W3023841799A5027835055 @default.
- W3023841799 hasAuthorship W3023841799A5047233660 @default.
- W3023841799 hasAuthorship W3023841799A5051415080 @default.
- W3023841799 hasAuthorship W3023841799A5082438764 @default.
- W3023841799 hasBestOaLocation W30238417991 @default.
- W3023841799 hasConcept C104317684 @default.
- W3023841799 hasConcept C121608353 @default.
- W3023841799 hasConcept C126322002 @default.
- W3023841799 hasConcept C135763542 @default.
- W3023841799 hasConcept C143998085 @default.
- W3023841799 hasConcept C2776694085 @default.
- W3023841799 hasConcept C2776802502 @default.
- W3023841799 hasConcept C2777511904 @default.
- W3023841799 hasConcept C2780110267 @default.
- W3023841799 hasConcept C2780849966 @default.
- W3023841799 hasConcept C530470458 @default.
- W3023841799 hasConcept C54355233 @default.
- W3023841799 hasConcept C71924100 @default.
- W3023841799 hasConcept C86803240 @default.
- W3023841799 hasConceptScore W3023841799C104317684 @default.
- W3023841799 hasConceptScore W3023841799C121608353 @default.
- W3023841799 hasConceptScore W3023841799C126322002 @default.
- W3023841799 hasConceptScore W3023841799C135763542 @default.
- W3023841799 hasConceptScore W3023841799C143998085 @default.
- W3023841799 hasConceptScore W3023841799C2776694085 @default.
- W3023841799 hasConceptScore W3023841799C2776802502 @default.
- W3023841799 hasConceptScore W3023841799C2777511904 @default.
- W3023841799 hasConceptScore W3023841799C2780110267 @default.
- W3023841799 hasConceptScore W3023841799C2780849966 @default.
- W3023841799 hasConceptScore W3023841799C530470458 @default.
- W3023841799 hasConceptScore W3023841799C54355233 @default.
- W3023841799 hasConceptScore W3023841799C71924100 @default.
- W3023841799 hasConceptScore W3023841799C86803240 @default.
- W3023841799 hasFunder F4320322665 @default.
- W3023841799 hasIssue "1" @default.
- W3023841799 hasLocation W30238417991 @default.
- W3023841799 hasLocation W30238417992 @default.
- W3023841799 hasLocation W30238417993 @default.
- W3023841799 hasOpenAccess W3023841799 @default.
- W3023841799 hasPrimaryLocation W30238417991 @default.
- W3023841799 hasRelatedWork W2020150632 @default.
- W3023841799 hasRelatedWork W2134503598 @default.
- W3023841799 hasRelatedWork W2331329572 @default.
- W3023841799 hasRelatedWork W2591616149 @default.
- W3023841799 hasRelatedWork W2783325361 @default.
- W3023841799 hasRelatedWork W3027584404 @default.